A Multi-Site Clinical Evaluation of the LIAISON NES FLU A/B, RSV & COVID-19 Assay in Symptomatic Patients

NARecruitingINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

September 30, 2024

Primary Completion Date

March 31, 2025

Study Completion Date

May 31, 2025

Conditions
Influenza aInfluenza BRSVCOVID 19
Interventions
DIAGNOSTIC_TEST

LIAISON NES FLU A/B, RSV & COVID-19

The LIAISON® NES FLU A/B, RSV \& COVID-19 assay used on the LIAISON® NES instrument is a real-time PCR system that enables the direct amplification, detection and differentiation of Flu A viral RNA, Flu B viral RNA RSV viral RNA, and SARS-CoV-2 RNA from dry nasal swabs. Nasal Swabs can be professionally collected by a Healthcare Provider or self-collected by the patient under the supervision of the healthcare provider. The collected nasal swab can then be directly loaded into the cartridge without nucleic acid extraction.

Trial Locations (3)

15227

RECRUITING

PAS Research - Pittsburgh, Pittsburgh

78504

RECRUITING

PAS Research - McAllen, McAllen

89014

RECRUITING

PAS Research - Henderson, Henderson

Sponsors
All Listed Sponsors
lead

DiaSorin Molecular LLC

INDUSTRY